1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Detalles Bibliográficos
Autores principales: Corey, Ralph, Wikler, Matthew, Moeck, Greg, Jiang, Hai, Good, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782154/
http://dx.doi.org/10.1093/ofid/ofu051.148
_version_ 1783295127557505024
author Corey, Ralph
Wikler, Matthew
Moeck, Greg
Jiang, Hai
Good, Samantha
author_facet Corey, Ralph
Wikler, Matthew
Moeck, Greg
Jiang, Hai
Good, Samantha
author_sort Corey, Ralph
collection PubMed
description
format Online
Article
Text
id pubmed-5782154
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57821542018-03-01 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Corey, Ralph Wikler, Matthew Moeck, Greg Jiang, Hai Good, Samantha Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782154/ http://dx.doi.org/10.1093/ofid/ofu051.148 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Corey, Ralph
Wikler, Matthew
Moeck, Greg
Jiang, Hai
Good, Samantha
1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title_full 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title_fullStr 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title_full_unstemmed 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title_short 1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
title_sort 1331 the solo studies: a single-dose of oritavancin (ori) compared to 7-10 days of vancomycin (van) in the treatment of acute bacterial skin and skin structure infections (absssi)
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782154/
http://dx.doi.org/10.1093/ofid/ofu051.148
work_keys_str_mv AT coreyralph 1331thesolostudiesasingledoseoforitavancinoricomparedto710daysofvancomycinvaninthetreatmentofacutebacterialskinandskinstructureinfectionsabsssi
AT wiklermatthew 1331thesolostudiesasingledoseoforitavancinoricomparedto710daysofvancomycinvaninthetreatmentofacutebacterialskinandskinstructureinfectionsabsssi
AT moeckgreg 1331thesolostudiesasingledoseoforitavancinoricomparedto710daysofvancomycinvaninthetreatmentofacutebacterialskinandskinstructureinfectionsabsssi
AT jianghai 1331thesolostudiesasingledoseoforitavancinoricomparedto710daysofvancomycinvaninthetreatmentofacutebacterialskinandskinstructureinfectionsabsssi
AT goodsamantha 1331thesolostudiesasingledoseoforitavancinoricomparedto710daysofvancomycinvaninthetreatmentofacutebacterialskinandskinstructureinfectionsabsssi

Ejemplares similares